NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 54 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $2,000 | 0.0% | 18,000 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $2,000 | -50.0% | 18,000 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $4,000 | 0.0% | 18,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $4,000 | -33.3% | 18,000 | 0.0% | 0.00% | -50.0% |
| Q1 2018 | $6,000 | 0.0% | 18,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $6,000 | -14.3% | 18,000 | 0.0% | 0.00% | -33.3% |
| Q3 2017 | $7,000 | -22.2% | 18,000 | 0.0% | 0.00% | -25.0% |
| Q2 2017 | $9,000 | -10.0% | 18,000 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $10,000 | -9.1% | 18,000 | 0.0% | 0.00% | -20.0% |
| Q4 2016 | $11,000 | -31.2% | 18,000 | 0.0% | 0.01% | -28.6% |
| Q3 2016 | $16,000 | +60.0% | 18,000 | 0.0% | 0.01% | +75.0% |
| Q2 2016 | $10,000 | -41.2% | 18,000 | 0.0% | 0.00% | -50.0% |
| Q1 2016 | $17,000 | -29.2% | 18,000 | 0.0% | 0.01% | -33.3% |
| Q4 2015 | $24,000 | -41.5% | 18,000 | 0.0% | 0.01% | -47.8% |
| Q3 2015 | $41,000 | +41.4% | 18,000 | 0.0% | 0.02% | +53.3% |
| Q2 2015 | $29,000 | 0.0% | 18,000 | 0.0% | 0.02% | 0.0% |
| Q1 2015 | $29,000 | -14.7% | 18,000 | 0.0% | 0.02% | -16.7% |
| Q4 2014 | $34,000 | +41.7% | 18,000 | 0.0% | 0.02% | +38.5% |
| Q3 2014 | $24,000 | -11.1% | 18,000 | 0.0% | 0.01% | -13.3% |
| Q2 2014 | $27,000 | -18.2% | 18,000 | 0.0% | 0.02% | -21.1% |
| Q1 2014 | $33,000 | -10.8% | 18,000 | 0.0% | 0.02% | -13.6% |
| Q4 2013 | $37,000 | -22.9% | 18,000 | 0.0% | 0.02% | -31.2% |
| Q3 2013 | $48,000 | 0.0% | 18,000 | 0.0% | 0.03% | -3.0% |
| Q2 2013 | $48,000 | – | 18,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|